Analysts Have Chosen: GWPH, APHA and CGC Are Top Cannabis Stock Picks

The cannabis market has the potential to be extremely lucrative for investors. For example, shares of cannabis grower Hexo (HEXO) are now up …

GW Pharmaceuticals (GWPH): A “Blue Chip” Cannabis Stock to Watch

By Genia Turanova For centuries, humans relied on plant-derived medicines, using — based on countless experiments and astute observation — a wide range …

GW Pharma (GWPH) Stock Could Surge on Earnings Today

GW Pharma (GWPH) has the distinction of having the first cannabis-derived prescription drug that was approved by the FDA: Epidiolex.  This drug is …

GW Pharmaceuticals (GWPH) Stock Finds a Fan in J.P Morgan

J.P Morgan analyst Cory Kasimov initiates coverage for medical cannabis company GW Pharmaceuticals (GWPH), calling it a “clear leader” in the field of cannabinoid …

Cantor Weighs in on GW Pharmaceuticals (GWPH) Stock Following DEA Rescheduling

This morning, GW Pharmaceuticals (GWPH) announced that EPIDIOLEX (cannabidiol) oral solution has been transferred to Schedule V, the lowest restriction classification, by the U.S.

GW Pharma (GWPH) Stock Gets Price-Target Hike Following FDA Approval

There’s a new FDA-approved cannabis-based medicine on the scene. Today, the U.

GW Pharmaceuticals (GWPH): Cowen Counts on ‘Wide Adoption’ for Epidiolex in Refractory Epilepsies

Cowen’s Phil Nadeau joins the bullish conversation buzzing about GWPh’s cannabis-based epilepsy drug after a unanimous nod from the FDA AdCom panel.

GW Pharmaceuticals (GWPH): Epidiolex Will Be Approved Much Before the PDUFA Date, Bets Cantor

Cantor’s Elemer Piros now expects 52% in return potential for GWPH stock and sets a 100% probability of success for Epidiolex.

GW Pharmaceuticals (GWPH) Lead Drug’s Green Light Just Around the Corner? Cowen Joins the Conversation

On back of yesterday’s positive briefing documents, Cowen’s Phil Nadeau roots for FDA approval.

Why GW Pharmaceuticals (GWPH) Stock Is Posting Strong Gains Today

GW Pharmaceuticals (NASDAQ:GWPH) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 11% upturn. …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts